NEW YORK (GenomeWeb) — A new agreement between Affymetrix and CollabRx that will allow clinical research labs to interpret microarray data within the architecture of CollabRx's Gene Variant Annotation Service showcases two market trends, according Gavin Gordon, CollabRx's vice president of busin